Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT03859752
TR1801-ADC in Patients With Tumors That Express c-Met
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 14, 2019
Completion: Dec 31, 2023